Association ofHTR2C, but notLEPorINSIG2, genes with antipsychotic-induced weight gain in a German sample

Leptin: a pivotal regulator of human energy homeostasis

(2009) I Sadaf Farooqi et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure

(2009) Vijay K. Yadav et al.   CELL

Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients

(2009) Hiroshi Ujike et al.   JOURNAL OF CLINICAL PSYCHIATRY

Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication

(2009) Jochem G. Gregoor et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia

(2009) Hans Mulder et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome

(2009) B Laika et al.   PHARMACOGENOMICS JOURNAL

Olanzapine-induced weight gain is associated with the −759C/T and −697G/C polymorphisms of the HTR2C gene

(2009) B R Godlewska et al.   PHARMACOGENOMICS JOURNAL

Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors

(2009) Shona L. Kirk et al.   PSYCHOPHARMACOLOGY

Weight effects associated with antipsychotics: A comprehensive database analysis

(2009) Bruce Parsons et al.   SCHIZOPHRENIA RESEARCH

Focus on HTR2C: A possible suggestion for genetic studies of complex disorders

(2008) Antonio Drago et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

(2008) Olga O. Yevtushenko et al.   BRITISH JOURNAL OF PSYCHIATRY

Association between a TGFβ1 promoter polymorphism and the phenotype of aspirin-intolerant chronic urticaria in a Korean population

(2008) H.-J. Park et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course

(2008) Stefan Gebhardt et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Performance of a neuro-fuzzy model in predicting weight changes of chronic schizophrenic patients exposed to antipsychotics

(2008) T H Lan et al.   MOLECULAR PSYCHIATRY

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

(2008) S Le Hellard et al.   MOLECULAR PSYCHIATRY

DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain

(2008) J Popp et al.   PHARMACOGENOMICS JOURNAL

The influence of 5-HT2C and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients

(2008) Martina Rojnic Kuzman et al.   PSYCHIATRY RESEARCH

Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?

(2008) M. J. Arranz et al.   SCHIZOPHRENIA BULLETIN

Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain

(2007) Seung-Gul Kang et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY